AlphaCentric Life Sciences & Hlthcare I (LYFIX)
| Fund Assets | 33.41M |
| Expense Ratio | 1.41% |
| Min. Investment | $2,500 |
| Turnover | 164.00% |
| Dividend (ttm) | 0.26 |
| Dividend Yield | 2.09% |
| Dividend Growth | -16.93% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 30, 2024 |
| Previous Close | 13.13 |
| YTD Return | 3.96% |
| 1-Year Return | -5.58% |
| 5-Year Return | 42.13% |
| 52-Week Low | 11.66 |
| 52-Week High | 14.28 |
| Beta (5Y) | n/a |
| Holdings | 65 |
| Inception Date | Nov 29, 2019 |
About LYFIX
AlphaCentric LifeSci Healthcare Fund Class I is a mutual fund focused on delivering long-term capital appreciation by investing primarily in the healthcare and life sciences sector. The fund allocates at least 80% of its net assets—plus borrowings—toward equities within the expansive healthcare industry, spanning large, mid, and small capitalization companies. Its portfolio is heavily weighted toward leading healthcare names, including major pharmaceuticals, biotechnology firms, healthcare equipment manufacturers, and managed care providers. Notable holdings feature industry leaders such as Eli Lilly and Co, UnitedHealth Group, Johnson & Johnson, and AbbVie, reflecting a blend of growth and value investment styles. The fund is characterized by a relatively high portfolio turnover, indicative of active management, and carries an expense ratio that places it among the higher-cost funds in its category. With a focus exclusively on healthcare, AlphaCentric LifeSci Healthcare Fund Class I offers investors targeted exposure to a sector that plays a vital role in both the global economy and advancements in medical technology and services.
Performance
LYFIX had a total return of -5.58% in the past year, including dividends. Since the fund's inception, the average annual return has been 9.23%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
Top 10 Holdings
43.79% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 8.28% |
| Johnson & Johnson | JNJ | 4.87% |
| AbbVie Inc. | ABBV | 4.63% |
| AstraZeneca PLC | AZN | 4.23% |
| First American Treasury Obligations Fund | FXFXX | 4.20% |
| UnitedHealth Group Incorporated | UNH | 3.98% |
| Boston Scientific Corporation | BSX | 3.88% |
| NOVARTIS AG-ADR | NVSN.MX | 3.66% |
| Merck & Co., Inc. | MRK | 3.45% |
| Vertex Pharmaceuticals Incorporated | VRTX | 2.60% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2024 | $0.0193 | Dec 31, 2024 |
| Dec 13, 2024 | $0.2634 | Dec 16, 2024 |
| Dec 14, 2023 | $0.3403 | Dec 15, 2023 |
| Dec 15, 2022 | $0.5494 | Dec 16, 2022 |
| Dec 16, 2021 | $1.6818 | Dec 17, 2021 |
| Dec 17, 2020 | $0.3515 | Dec 17, 2020 |